Potential clinical insights into microRNAs and their target genes in esophageal carcinoma

References

• Banerjee HN, Verma M. (2009). Epigenetic mechanisms in cancer. Biomark Med 3:397–410.
   PubMed Web of Science ®Google Scholar
• Bohnsack MT, Czaplinski K, Gorlich D. (2004). Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. Rna 10:185–191.
   PubMed Web of Science ®Google Scholar
• Borchert GM, Lanier W, Davidson BL. (2006). RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 13:1097–1101.
   PubMed Web of Science ®Google Scholar
• Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, Shiekhattar R. (2005). TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436:740–744.
   PubMed Web of Science ®Google Scholar
• Cho WC. (2010). MicroRNAs in cancer - from research to therapy. Biochim Biophys Acta 1805:209–217.
   PubMed Web of Science ®Google Scholar
• Dijckmeester WA, Wijnhoven BP, Watson DI, Leong MP, Michael MZ, Mayne GC, Bright T, Astill D, Hussey DJ. (2009). MicroRNA-143 and -205 expression in neosquamous esophageal epithelium following Argon plasma ablation of Barrett’s esophagus. j Gastrointest Surg 13:846–853.
   PubMed Web of Science ®Google Scholar
• Elmén J, Lindow M, Schütz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjärn M, Hansen HF, Berger U, Gullans S, Kearney P, Sarnow P, Straarup EM, Kauppinen S. (2008). LNA-mediated microRNA silencing in non-human primates. Nature 452:896–899.
   PubMed Web of Science ®Google Scholar
• Esteller M. (2008). Epigenetics in cancer. n Engl j Med 358:1148–1159.
   PubMed Web of Science ®Google Scholar
• Fassan M, Mescoli C, Volinia S, Pizzi M, Palatini J, Baffa R, Clemente R, Rizzetto C, Croce C, Zaninotto G, Ancona E, Rugge M (2010) Micrornas are deregulated in Barrett’s carcinogenesis. Digestive and Liver Disease 42: S146
   Google Scholar
• Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, Wu M, Swanson SJ, Godfrey TE, Litle VR. (2008). MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg 135:255–60. discussion 260.
   PubMed Web of Science ®Google Scholar
• Garofalo M, Croce CM. (2011). microRNAs: Master regulators as potential therapeutics in cancer. Annu Rev Pharmacol Toxicol 51:25–43.
   PubMed Web of Science ®Google Scholar
• Garzon R, Calin GA, Croce CM. (2009). MicroRNAs in Cancer. Annu Rev Med 60:167–179.
   PubMed Web of Science ®Google Scholar
• Garzon R, Marcucci G, Croce CM. (2010). Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 9:775–789.
   PubMed Web of Science ®Google Scholar
• Guo Y, Chen Z, Zhang L, Zhou F, Shi S, Feng X, Li B, Meng X, Ma X, Luo M, Shao K, Li N, Qiu B, Mitchelson K, Cheng J, He J. (2008). Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 68:26–33.
   PubMed Web of Science ®Google Scholar
• Harata K, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Ogawa R, Katada T, Tanaka T, Shiozaki M, Fujii Y. (2010). MicroRNA-34b has an oncogenic role in esophageal squamous cell carcinoma. Oncol Lett 1:685–689
   Google Scholar
• Harris CC. (2010) Interweaving microRNA, inflammatory cytokine and p53 pathways in human cancer. EurJ Canc, Supplement 8:7–8
   Google Scholar
• Hiyoshi Y, Kamohara H, Karashima R, Sato N, Imamura Y, Nagai Y, Yoshida N, Toyama E, Hayashi N, Watanabe M, Baba H. (2009). MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res 15:1915–1922.
   PubMed Web of Science ®Google Scholar
• Hong L, Han Y, Zhang H, Li M, Gong T, Sun L, Wu K, Zhao Q, Fan D. (2010). The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Ann Surg 251:1056–1063.
   PubMed Web of Science ®Google Scholar
• Hu Y, Correa AM, Hoque A, Guan B, Ye F, Huang J, Swisher SG, Wu TT, Ajani JA, Xu XC. (2011). Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int j Cancer 128:132–143.
   PubMed Web of Science ®Google Scholar
• Hummel R, Hussey DJ, Michael MZ, Haier J, Bruewer M, Senninger N, Watson DI. (2011). MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma. Ann Surg Oncol 18:253–260.
   PubMed Web of Science ®Google Scholar
• Inoue N, Isomoto H, Matsushima K, Hayashi T, Kunizaki M, Hidaka S, Machida H, Mitsutake N, Nanashima A, Takeshima F, Nakayama T, Ohtsuru A, Nakashima M, Nagayasu T, Yamashita S, Nakao K, Kohno S. (2010) Down-regulation of microRNA 10a expression in esophageal squamous cell carcinoma cells. Oncol Lett 1:527–531
   Google Scholar
• Kan T, Meltzer SJ. (2009). MicroRNAs in Barrett’s esophagus and esophageal adenocarcinoma. Curr Opin Pharmacol 9:727–732.
   Google Scholar
• Kan T, Sato F, Ito T, Matsumura N, David S, Cheng Y, Agarwal R, Paun BC, Jin Z, Olaru AV, Selaru FM, Hamilton JP, Yang J, Abraham JM, Mori Y, Meltzer SJ. (2009). The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 136:1689–1700.
   PubMed Web of Science ®Google Scholar
• Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M, Matsubara H. (2010). miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int j Cancer 127:2804–2814.
   PubMed Web of Science ®Google Scholar
• Kim VN. (2005). MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6:376–385.
   PubMed Web of Science ®Google Scholar
• Kim YK, Kim VN. (2007). Processing of intronic microRNAs. Embo J 26:775–783.
   PubMed Web of Science ®Google Scholar
• Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S, Sano K, Itoh H. (2010). Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep 23:1625–1633.
   PubMed Web of Science ®Google Scholar
• Kitade Y, Akao Y. (2010). MicroRNAs and their therapeutic potential for human diseases: microRNAs, miR-143 and -145, function as anti-oncomirs and the application of chemically modified miR-143 as an anti-cancer drug. j Pharmacol Sci 114:276–280.
   PubMed Web of Science ®Google Scholar
• Kota J, Chivukula RR, O’Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT. (2009). Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137:1005–1017.
   PubMed Web of Science ®Google Scholar
• Lee KH, Goan YG, Hsiao M, Lee CH, Jian SH, Lin JT, Chen YL, Lu PJ. (2009). MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer. Exp Cell Res 315:2529–2538.
   PubMed Web of Science ®Google Scholar
• Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN. (2004). MicroRNA genes are transcribed by RNA polymerase II. Embo J 23:4051–4060.
   PubMed Web of Science ®Google Scholar
• Luthra R, Singh RR, Luthra MG, Li YX, Hannah C, Romans AM, Barkoh BA, Chen SS, Ensor J, Maru DM, Broaddus RR, Rashid A, Albarracin CT. (2008). MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 27:6667–6678.
   PubMed Web of Science ®Google Scholar
• Lv J, Cao XF, Zhu B, Ji L, Tao L, Wang DD. (2009). Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma. World j Gastroenterol 15:4962–4968.
   Google Scholar
• Maru DM, Singh RR, Hannah C, Albarracin CT, Li YX, Abraham R, Romans AM, Yao H, Luthra MG, Anandasabapathy S, Swisher SG, Hofstetter WL, Rashid A, Luthra R. (2009). MicroRNA-196a is a potential marker of progression during Barrett’s metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am j Pathol 174:1940–1948.
   PubMed Web of Science ®Google Scholar
• Mathé EA, Nguyen GH, Bowman ED, Zhao Y, Budhu A, Schetter AJ, Braun R, Reimers M, Kumamoto K, Hughes D, Altorki NK, Casson AG, Liu CG, Wang XW, Yanaihara N, Hagiwara N, Dannenberg AJ, Miyashita M, Croce CM, Harris CC. (2009). MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 15:6192–6200.
   PubMed Web of Science ®Google Scholar
• Matsushima K, Isomoto H, Inoue N, Nakayama T, Fukuda M, Akazawa Y, Yamaguchi N, Ohnita K, Takeshima F, Nakao K. (2010a) Involvement of micrornas in the invasion of esophageal cancer cells. AnnOncol 21: viii48
   Google Scholar
• Matsushima K, Isomoto H, Kohno S, Nakao K. (2010b). MicroRNAs and esophageal squamous cell carcinoma. Digestion 82:138–144.
   PubMed Web of Science ®Google Scholar
• Melo SA, Moutinho C, Ropero S, Calin GA, Rossi S, Spizzo R, Fernandez AF, Davalos V, Villanueva A, Montoya G, Yamamoto H, Schwartz S Jr, Esteller M. (2010). A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 18:303–315.
   PubMed Web of Science ®Google Scholar
• Merritt WM, Bar-Eli M, Sood AK. (2010). The dicey role of Dicer: implications for RNAi therapy. Cancer Res 70:2571–2574.
   Google Scholar
• Mori Y, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Ogawa R, Katada T, Harata K, Tanaka T, Shiozaki M, Fujii Y. (2009). MicroRNA-21 induces cell proliferation and invasion in esophageal squamous cell carcinoma. Mol Med Report 2:235–239.
   Web of Science ®Google Scholar
• Nguyen GH, Schetter AJ, Chou DB, Bowman ED, Zhao R, Hawkes JE, Mathé EA, Kumamoto K, Zhao Y, Budhu A, Hagiwara N, Wang XW, Miyashita M, Casson AG, Harris CC. (2010). Inflammatory and microRNA gene expression as prognostic classifier of Barrett’s-associated esophageal adenocarcinoma. Clin Cancer Res 16:5824–5834.
   PubMed Web of Science ®Google Scholar
• Ogawa R, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Katada T, Harata K, Tanaka T, Fujii Y. (2009). Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med Mol Morphol 42:102–109.
   PubMed Web of Science ®Google Scholar
• Ohashi S, Kalman RA, Natsuizaka M, Grugan KD, Stairs DB, Kalabis J, Andl C, Yang Y, Rhoades B, Pear WS, Katz JP, Nakagawa H. (2009) Genetic Ablation of the notch signaling promotes TGF-(β)-induced epithelial-mesenchymal transition involving posttranscriptional regulation of ZEB1 and ZEB2 By MicroRNA-200 family members. Gastroenterol 136:A54
   Google Scholar
• Ohta M, Mimori K, Fukuyoshi Y, Kita Y, Motoyama K, Yamashita K, Ishii H, Inoue H, Mori M. (2008). Clinical significance of the reduced expression of G protein gamma 7 (GNG7) in oesophageal cancer. Br j Cancer 98:410–417.
   PubMed Web of Science ®Google Scholar
• Petrocca F, Lieberman J. (2009). Micromanipulating cancer: microRNA-based therapeutics? rna Biol 6:335–340.
   Web of Science ®Google Scholar
• Sharma S, Kelly TK, Jones PA. (2010). Epigenetics in cancer. Carcinogenesis 31:27–36.
   PubMed Web of Science ®Google Scholar
• Smith CM, Watson DI, Michael MZ, Hussey DJ. (2010). MicroRNAs, development of Barrett’s esophagus, and progression to esophageal adenocarcinoma. World j Gastroenterol 16:531–537.
   PubMed Web of Science ®Google Scholar
• Takashima N, Ishiguro H, Kuwabara Y, Kimura M, Haruki N, Ando T, Kurehara H, Sugito N, Mori R, Fujii Y. (2006). Expression and prognostic roles of PABPC1 in esophageal cancer: correlation with tumor progression and postoperative survival. Oncol Rep 15:667–671.
   PubMed Web of Science ®Google Scholar
• Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H, Liu Z. (2010). MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. j Biol Chem 285:7986–7994.
   PubMed Web of Science ®Google Scholar
• Tischoff I, Tannapfel A. (2008). Barrett’s esophagus: can biomarkers predict progression to malignancy? Expert Rev Gastroenterol Hepatol 2:653–663.
   PubMedGoogle Scholar
• Tsuchiya S, Fujiwara T, Sato F, Shimada Y, Tanaka E, Sakai Y, Shimizu K, Tsujimoto G. (2011). MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). j Biol Chem 286:420–428.
   PubMed Web of Science ®Google Scholar
• Van Baal J, Vleggaar FP, Siersema PD. (2009) Are MicroRNA-215 and 199a-5p potentially useful biomarkers in the development of Barrett’s esophagus and esophageal adenocarcinoma? Gastroenterol 136:A304
   Google Scholar
• Wang J, Sui M, Fan W. (2010). Nanoparticles for tumor targeted therapies and their pharmacokinetics. Curr Drug Metab 11:129–141.
   PubMed Web of Science ®Google Scholar
• Wang V, Wu W. (2009). MicroRNA-based therapeutics for cancer. Biodrugs 23:15–23.
   PubMed Web of Science ®Google Scholar
• Wijnhoven BP, Hussey DJ, Watson DI, Tsykin A, Smith CM, Michael MZ; South Australian Oesophageal Research Group. (2010). MicroRNA profiling of Barrett’s oesophagus and oesophageal adenocarcinoma. Br j Surg 97:853–861.
   PubMed Web of Science ®Google Scholar
• Wu BL, Xu LY, Du ZP, Liao LD, Zhang HF, Huang Q, Fang GQ, Li EM. (2011). MiRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145. World j Gastroenterol 17:79–88.
   PubMed Web of Science ®Google Scholar
• Wu W. (2011). Modulation of microRNAs for potential cancer therapeutics. Methods Mol Biol 676:59–70.
   Google Scholar
• Yang H, Gu J, Wang KK, Zhang W, Xing J, Chen Z, Ajani JA, Wu X. (2009). MicroRNA expression signatures in Barrett’s esophagus and esophageal adenocarcinoma. Clin Cancer Res 15:5744–5752.
   PubMed Web of Science ®Google Scholar
• Ye Y, Wang KK, Gu J, Yang H, Lin J, Ajani JA, Wu X. (2008). Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res (Phila) 1:460–469.
   PubMed Web of Science ®Google Scholar
• Yoshino M, Ishiwata T, Watanabe M, Matsunobu T, Komine O, Ono Y, Yamamoto T, Fujii T, Matsumoto K, Tokunaga A, Naito Z. (2007). Expression and roles of keratinocyte growth factor and its receptor in esophageal cancer cells. Int j Oncol 31:721–728.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Gong DJ, Liu XH, Lu FL. (2010). MiR-203 inhibits proliferation and invasion of esophageal squamous cell carcinoma. Academic Journal of Second Military Medical University 31: 818–821.
   Google Scholar
• Yuan Y, Zeng ZY, Liu XH, Gong DJ, Tao J, Cheng HZ, Huang SD. (2011). MicroRNA-203 inhibits cell proliferation by repressing ?Np63 expression in human esophageal squamous cell carcinoma. bmc Cancer 11:57.
   Google Scholar
• Zhang H, Li M, Han Y, Hong L, Gong T, Sun L, Zheng X. (2010). Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Dig Dis Sci 55:2545–2551.
   PubMed Web of Science ®Google Scholar